LAS VEGAS–(BUSINESS WIRE)–Moneta Health, a brain health company pioneering cognitive rehabilitation therapy through AI-powered delivery, today announced a $4.5 million funding round and a new partnership with Benefis Health System to expand access to cognitive care in neurology deserts. The company has signed a multi-year partnership with Benefis Health System in Montana and secured investment from venture capital firms including True Ventures and Health2047, the American Medical Association’s venture studio, to support its mission of expanding access to cognitive care, with a focus on regions with insufficient access to neurology care.

We do physical therapy for our bodies. Why not for our brains?Share

Cognitive impairment affects 32% of adults over 65, impacting 250 million people globally. Despite the demand for treatment, many are told that effective options are limited. “Cognitive rehabilitation therapy, which is like physical therapy for the brain, is a proven behavioral intervention for slowing cognitive decline and preserving independence,” explains Moneta Health co-founder Jen Flexman. “Despite the benefits, fewer than 20% of patients are accessing this treatment in outpatient settings.”

Through Moneta’s clinically-proven program, patients speak with their licensed therapist by phone, and engage in cognitive exercises between visits with Moneta’s AI-powered therapy assistant by phone, eliminating the need for apps or a high-speed internet connection.

Moneta shared its real-world clinical outcomes at the recent Alzheimer’s Association International Conference in Toronto. Over the course of the program, patients’ cognitive function significantly improved on average by 18%, which exceeds the U.S. national benchmark of 13% for traditional outpatient therapy.

“Making cognitive care more accessible is a personal mission,” said Paul A. Campbell, co-founder and CEO of Moneta Health. “My mother was diagnosed with dementia in 2017. I wish we had a platform like Moneta earlier in our family’s journey to maintain her cognitive function for longer.”

Moneta is backed by investment from leading venture capital firms and global investors including True Ventures, Health2047, Impact America Fund, BKR Capital, Koru, Ontario Teachers’ Pension Plan and the Centre for Aging + Brain Health Innovation (CABHI), and recently closed a $4.5 million USD round.

“Physicians everywhere are struggling to find effective, scalable solutions for patients with complex cognitive needs, particularly in regions with few or no neurologists,” said Lawrence K. Cohen, PhD, CEO of Health2047. “Moneta’s model brings clinically proven therapy directly to patients’ homes, giving physicians a new solution to address this critical gap in care.” The investment will fuel product development, clinical research, and expansion into other underserved regions.

This funding follows a $2.2M pre-seed round raised in March 2023, led by True Ventures shortly after Moneta was founded. “Moneta is the second time we’ve invested in a company founded by Paul. The company is solving an important problem in a growing market that touches so many lives,” said Phil Black, co-founding partner at True Ventures.

Along with funding, Moneta has announced a multi-year partnership with Montana-based Benefis Health System to integrate its cognitive rehab platform into the health system’s healthy aging care pathway. “We are excited to partner with Moneta to make personalized, evidence-based cognitive rehabilitation the standard of care for our patients and families,” noted Dr. Greg Tierney, President of System Clinical Operations at Benefis Health System. “Montana is vast and has the sixth oldest population in the nation. Moneta’s proven program is an accessible approach to proactive brain health for our aging demographic.”

In addition to operating in Montana, Moneta’s virtual clinic treats patients in Florida, Nevada, Washington, and West Virginia, with plans to expand nationally. The program is reimbursed by Medicare, TRICARE and a growing number of Medicare Advantage plans including Aetna, Blue Cross, Humana, OPTUM and Sunshine Health.

As cognitive impairment and dementia rates continue to rise, Moneta aims to redefine how therapy is delivered and reimagine the treatment and prevention of cognitive decline. With its unique model, the company is actively building partnerships with additional health systems, payers, and community-based organizations across the U.S.

About Moneta Health

Moneta Health is a brain health company delivering evidence-based cognitive rehabilitation therapy through an innovative blend of voice AI and licensed therapists. Designed for accessibility, the company provides care via telephone to reach patients at home in rural areas and underserved populations. Moneta is backed by True Ventures, Health2047 (the American Medical Association’s venture studio), Impact America Fund, BKR Capital, and the Centre for Aging + Brain Health Innovation (CABHI). The company is also a member of StartUp Health’s Alzheimer’s Moonshot community and the NIH’s A2 Collective. Moneta, named after the Roman goddess of memory, was co-founded by Paul A. Campbell and Jen Flexman. Learn more at www.moneta.health.

Contacts

Media Contact: media@moneta.health

(c)2025 Business Wire, Inc., All rights reserved.